MAPT and Alzheimer disease: Current evidence suggests that mitochondrial impairment is also a hallmark of AD, as mitochondrial dysfunction appears before the establishment of tau and Aβ pathology contributing to synaptic impairment observed in AD (Knott et al., 2008; Cabezas-Opazo et al., 2015, Yao et al., 2011).